Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Pharma Mar SA ( (ES:PHM) ).
Pharma Mar S.A. has reported on its share buyback program, detailing transactions between January 13 and 17, 2025. This buyback initiative is part of the company’s strategic efforts to stabilize its stock price and enhance shareholder value, reflecting a proactive approach to managing its financial health and market presence.
More about Pharma Mar SA
Pharma Mar S.A. operates in the pharmaceutical industry, primarily focusing on the development and commercialization of marine-derived drugs for oncology and other therapeutic uses.
YTD Price Performance: -3.01%
Average Trading Volume: 356
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.42B
See more data about PHM stock on TipRanks’ Stock Analysis page.
